Unexplained variation across US nursing homes in antipsychotic prescribing rates

Archives of Internal Medicine

Volumn 170, Issue 1, 2010, Pages 89-95

  Chen, Yong ^a   Briesacher, Becky A ^a   Field, Terry S ^a   Tjia, Jennifer ^a   Lau, Denys T ^b   Gurwitz, Jerry H ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; BEHAVIOR DISORDER; DEMENTIA; DRUG INDICATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; NURSING HOME; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOSIS; UNITED STATES;

AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; CHI-SQUARE DISTRIBUTION; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NURSING HOMES; PHYSICIAN'S PRACTICE PATTERNS; POISSON DISTRIBUTION; UNITED STATES;

EID: 74549139690     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2009.469     Document Type: Article

References (26)

1. Lagnado L. Nursing homes struggle to kick drug habit. 2007. http://online.wsj.com/article/SB119811286789841083.html. Accessed December 2007.
2. Public Health Advisory. Death With Antipsychotics in Elderly. Rockville, MD: Food and Drug Administration; 2005.
3. Briesacher BA, Limcangco MR, Simoni-Wastila L, et al. The quality of antipsychotic drug prescribing in nursing homes. Arch Intern Med. 2005;165(11):1280-1285.
4. Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA. 2005;294(15):1934-1943.
5. Schneider LS, Tariot PN, Dagerman KS, et al; CATIE-AD Study Group. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. N Engl J Med. 2006;355(15):1525-1538.
6. Rochon PA, Stukel TA, Bronskill SE, et al. Variation in nursing home antipsychotic prescribing rates. Arch Intern Med. 2007;167(7):676-683.
7. Hughes CM, Lapane K, Watson MC, Davies HT. Does organisational culture influence prescribing in care homes for older people? a new direction for research. Drugs Aging. 2007;24(2):81-93.
8. Briesacher BA, Soumerai SB, Field TS, Fouayzi H, Gurwitz JH. Nursing home residents and enrollment in Medicare Part D. J Am Geriatr Soc. 2009;57(10):1902-1907.
9. Hawes C, Morris JN, Phillips CD, Mor V, Fries BE, Nonemaker S. Reliability estimates for the Minimum Data Set for nursing home resident assessment and care screening (MDS). Gerontologist. 1995;35(2):172-178.
10. Snowden M, McCormick W, Russo J, et al. Validity and responsiveness of the Minimum Data Set. J Am Geriatr Soc. 1999;47(8):1000-1004.
11. Doshi JA, Shaffer T, Briesacher BA. National estimates of medication use in nursing homes: findings from the 1997 Medicare current beneficiary survey and the 1996 medical expenditure survey. J Am Geriatr Soc. 2005;53(3):438-443.
12. Keeler EB, Kane RL, Solomon DH. Short- and long-term residents of nursing homes. Med Care. 1981;19(3):363-370.
13. Hirdes JP, Frijters DH, Teare GF. The MDS-CHESS scale: a new measure to predict mortality in institutionalized older people. J Am Geriatr Soc. 2003;51(1):96-100.
14. Liperoti R, Gambassi G, Lapane KL, et al. Conventional and atypical antipsychotics and the risk of hospitalization for ventricular arrhythmias or cardiac arrest. Arch Intern Med. 2005;165(6):696-701.
15. Liperoti R, Mor V, Lapane KL, Pedone C, Gambassi G, Bernabei R. The use of atypical antipsychotics in nursing homes. J Clin Psychiatry. 2003;64(9):1106-1112.
16. Snowden M, Sato K, Roy-Byrne P. Assessment and treatment of nursing home residents with depression or behavioral symptoms associated with dementia: a review of the literature. J Am Geriatr Soc. 2003;51(9):1305-1317.
17. Morris JN, Fries BE, Mehr DR, et al. MDS Cognitive Performance Scale. J Gerontol. 1994;49(4):M174-M182.
18. Oliveria SA, Liperoti R, L'Italien G, et al. Adverse events among nursing home residents with Alzheimer's disease and psychosis. Pharmacoepidemiol Drug Saf. 2006;15(11):763-774.
19. Greenland S. Model-based estimation of relative risks and other epidemiologic measures in studies of common outcomes and in case-control studies. Am J Epidemiol. 2004;160(4):301-305.
20. Crystal S, Olfson M, Huang C, Pincus H, Gerhard T. Broadened use of atypical antipsychotics: safety, effectiveness, and policy challenges. Health Aff (Millwood). 2009;28(5):w770-w781.
21. Mitchell SL, Teno JM, Roy J, Kabumoto G, Mor V. Clinical and organizational factors associated with feeding tube use among nursing home residents with advanced cognitive impairment. JAMA. 2003;290(1):73-80.
22. Gruneir A, Lapane KL. It is time to assess the role of organizational culture in nursing home prescribing patterns [letter]. Arch Intern Med. 2008;168(2):238-239.
23. Anderson GM, Rochon PA. It is time to assess the role of organizational culture in nursing home prescribing patterns [in reply]. Arch Intern Med. 2008;168(2):239.
24. Nursing Facility Total. Average and Median Number of Patients Per Facility and ADL Dependence. Washington, DC: American Health Care Association; 2006.
25. Katz PR, Karuza J, Intrator O, et al. Medical staff organization in nursing homes: scale development and validation. J Am Med Dir Assoc. 2009;10(7):498-504.
26. Lau DT, Kasper JD, Potter DE, Lyles A. Potentially inappropriate medication prescriptions among elderly nursing home residents: their scope and associated resident and facility characteristics. Health Serv Res. 2004;39(5):1257-1276.